[A prognostic value of level of antiviral antibodies in the development of recurrence of bladder cancer].

Introduction: Serological diagnosis of virus-associated tumors attracts the attention of many specialists. The changes in the level of antiviral antibodies in tumors of different localizations are proved. In some cases, the authors suggest using these data either for screening of tumors or for controlling the cure.

[High oncogenic risk human papillomavirus and urinary bladder cancer].

Aim: To determine the role of human papillomavirus (HPV) of high oncogenic risk in the development of urinary bladder cancer.

Materials And Methods: 100 patients (72 men and 28 women) aged 38 to 90 years (mean age 65+/-10 years) diagnosed with bladder cancer were examined and underwent treatment. Clinical assessment was complemented by enzyme-linked immunosorbent assays for the presence of antiviral antibodies to herpes simplex virus (HSV) type 1 and type 2, cytomegalovirus (CMV), Epstein-Barr virus (EBV), urethra scraping for detecting high oncogenic risk HPV.